Opportunity Information: Apply for CDC RFA GH11 1134
Apply for CDC RFA GH11 1134
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Supporting the Safe, Adequate and Reliable Supply of Blood and Blood Products through the Malawi Blood Transfusion Service and its Support to Hospitals throughout Malawi, under the PEPFAR and the Global Health Initiative" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067 Global AIDS.
- This funding opportunity was created on Jan 20, 2011 and posted on Jan 20, 2011.
- Applicants must submit their applications by Mar 22, 2011. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $20,000,000.00 to eligible and selected applicants.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- This funding announcement is not a request for applications. This is a public notice of the Centers for Disease Control and Prevention s intention to fund the project activities described within the full announcement without full and open competition.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This grant opportunity, issued by the U.S. Centers for Disease Control and Prevention (CDC) under PEPFAR and the Global Health Initiative, focuses on strengthening Malawi's national blood transfusion system so it can consistently deliver a safe, adequate, and reliable supply of blood and blood products to hospitals across the country. The central aim is to help the Malawi Blood Transfusion Service (MBTS) fully achieve its nationwide scope and mandate, meaning it should be able to meet transfusion needs for all patients in all hospitals in Malawi rather than serving only certain regions or facilities. In practical terms, the opportunity is about ensuring blood is both available in sufficient quantities and collected, processed, tested, stored, and distributed in a way that protects patients from transfusion-transmitted infections and other risks, while supporting hospitals so they can appropriately request, receive, and use blood and blood products.
The award mechanism is a cooperative agreement, which typically means CDC expects to have substantial involvement in the implementation and oversight of program activities compared to a standard grant. The activity area is categorized as health, and it is linked to CFDA 93.067 (Global AIDS), reflecting the connection to HIV-related prevention and care priorities. Although transfusion services benefit the entire health system, the PEPFAR linkage highlights the importance of preventing HIV transmission through blood and ensuring that blood safety systems remain strong and standardized nationwide.
Financially, the notice lists an estimated total funding amount of $20,000,000, with an expectation of one award. The listing shows an award ceiling and floor of $0, which commonly appears in postings where the precise structure of yearly budgets, ceilings, or allocations is defined in the full announcement rather than in the summary fields. There is no cost sharing or matching requirement, so recipients would not be required to contribute a set percentage of non-federal funds to participate.
A key detail is that this posting is explicitly not a request for applications. Instead, it serves as a public notice of CDC's intent to fund the described activities without full and open competition. That wording signals a limited-competition or directed funding approach, where CDC already anticipates supporting a specific implementing partner or set of partners based on programmatic considerations, existing relationships, or unique capabilities needed to carry out the work. Eligibility is therefore not presented in the usual open-competition sense; it is listed as "Others" with clarification intended in the full announcement, reinforcing that this is more of a notice of intent than an invitation for broad applicant submissions.
The timeline in the posting shows it was published on January 20, 2011, with an original and current closing date of March 22, 2011, and an archive date of April 21, 2011. Those dates indicate the historical window during which the notice and associated documentation were available as a live opportunity record, even though the notice itself states that it is not an open application solicitation.
For access and technical issues, the contact point provided is CDC's Procurement and Grants Office (PGO), Technical Information Management Section (TIMS), with a phone number for assistance in obtaining the full announcement materials. The "Additional Information" link field indicates it is not an active link and directs readers to select "Full Announcement" from the top of the listing, which is consistent with older grants.gov style postings where attachments were accessed through the record rather than an external URL.
Overall, the opportunity is best understood as a CDC-supported, PEPFAR-aligned investment in Malawi's national blood transfusion infrastructure and operations, designed to expand and standardize MBTS capacity nationwide and ensure hospitals throughout Malawi can depend on timely access to safe blood and blood products for all patients who need transfusion services.
Frequently Asked Questions (FAQs)
1) What is the main purpose of this CDC funding opportunity?
The opportunity focuses on strengthening Malawi's national blood transfusion system so it can consistently provide a safe, adequate, and reliable supply of blood and blood products to hospitals across Malawi. The core aim is to help the Malawi Blood Transfusion Service (MBTS) fully achieve a nationwide scope and mandate, meaning it can meet transfusion needs for patients in all hospitals rather than serving only certain regions or facilities.
2) Which country and national program are the activities intended to support?
The activities are intended to support Malawi, with specific emphasis on strengthening the Malawi Blood Transfusion Service (MBTS) and the national blood transfusion system that supplies hospitals across the country.
3) What types of improvements or outcomes are emphasized in the description?
The description emphasizes both availability and safety. It highlights improving how blood is collected, processed, tested, stored, and distributed to reduce transfusion-transmitted infections and other risks, while also supporting hospitals so they can appropriately request, receive, and use blood and blood products.
4) How does the opportunity define "safe" blood and blood products in practical terms?
"Safe" is framed as blood that is handled through systems that protect patients from transfusion-transmitted infections and other transfusion-related risks. The posting specifically points to standardized processes for collection, processing, testing, storage, and distribution as the practical pathway to safety.
5) What does it mean that MBTS should achieve a "nationwide scope and mandate"?
It means MBTS should be able to meet transfusion needs for all patients in all hospitals in Malawi, rather than serving only particular regions, facilities, or parts of the health system.
6) What is the award mechanism for this opportunity?
The award mechanism is a cooperative agreement. This typically indicates CDC expects substantial involvement in implementation and oversight of program activities compared with a standard grant.
7) What does "cooperative agreement" suggest about CDC's role during implementation?
Based on the posting, it suggests CDC would have substantial involvement in the implementation and oversight of activities. In other words, the relationship is expected to be more collaborative and actively managed than a traditional grant where the recipient operates with less direct federal involvement.
8) Which funding initiatives are referenced in the opportunity?
The opportunity is issued by the U.S. Centers for Disease Control and Prevention (CDC) under PEPFAR and the Global Health Initiative.
9) How is this opportunity linked to HIV-related priorities?
The posting is linked to CFDA 93.067 (Global AIDS) and describes the PEPFAR connection as highlighting the importance of preventing HIV transmission through blood and maintaining strong, standardized national blood safety systems.
10) What is the activity area/category listed for this opportunity?
The activity area is categorized as health.
11) What is the CFDA number associated with this opportunity, and what does it indicate?
The CFDA number is 93.067 (Global AIDS). In this posting, that designation reflects the connection to HIV-related prevention and care priorities, particularly the importance of safe blood to prevent HIV transmission via transfusion.
12) What is the estimated total funding amount and how many awards are expected?
The estimated total funding amount listed is $20,000,000, and the posting indicates an expectation of one award.
13) Why do the award ceiling and award floor show $0?
The summary fields show an award ceiling and floor of $0, which commonly appears when the precise structure of yearly budgets, ceilings, or allocations is defined in the full announcement rather than in the brief summary fields.
14) Is cost sharing or matching required?
No. The posting states there is no cost sharing or matching requirement, meaning recipients are not required to contribute a specified percentage of non-federal funds to participate.
15) Is this posting an open Request for Applications (RFA)?
No. The posting explicitly states it is not a request for applications. It is described as a public notice of CDC's intent to fund the described activities without full and open competition.
16) What does "without full and open competition" mean in this context?
The language signals a limited-competition or directed funding approach. The description indicates CDC already anticipates supporting a specific implementing partner or set of partners based on programmatic considerations, existing relationships, or unique capabilities needed for the work.
17) Who is listed as eligible to apply?
Eligibility is listed as "Others," with clarification intended in the full announcement. The posting also stresses that it is not an open solicitation, which is consistent with eligibility not being presented in the typical open-competition format.
18) If this is not an open solicitation, what should interested parties do?
Based on the information provided, the appropriate step is to consult the "Full Announcement" materials referenced in the posting for any eligibility clarification and details on the intended funding approach.
19) What are the key dates shown in the listing?
The posting shows it was published on January 20, 2011. The original and current closing date is March 22, 2011. The archive date is April 21, 2011.
20) What do the closing and archive dates imply about the opportunity?
The dates indicate the historical window when the notice and associated documentation were available as a live opportunity record. The description also states it was not an open application solicitation, even during that window.
21) Where should someone look to access the full announcement materials?
The posting indicates the "Additional Information" link is not active and directs readers to select "Full Announcement" from the top of the listing, which is consistent with older grants.gov style postings where attachments were accessed through the record.
22) Who is the contact for access or technical issues related to the announcement materials?
The contact point provided is CDC's Procurement and Grants Office (PGO), Technical Information Management Section (TIMS), with a phone number for assistance in obtaining the full announcement materials.
23) What role do hospitals play in the scope of the activities described?
Hospitals are described as key end users of the blood supply system. The opportunity emphasizes supporting hospitals so they can appropriately request, receive, and use blood and blood products, alongside improvements in national-level collection, testing, storage, and distribution.
24) How should this opportunity be summarized at a high level?
It is best understood as a CDC-supported, PEPFAR-aligned investment in Malawi's national blood transfusion infrastructure and operations, aimed at expanding and standardizing MBTS capacity nationwide so hospitals throughout Malawi can depend on timely access to safe blood and blood products for all patients who need transfusion services.
Browse more opportunities from the same agency: Centers for Disease Control and Prevention
Browse more opportunities from the same category: Health
Next opportunity: Supporting the Ministry of Public Health, Directorate of Family Health to Integrate Comprehensive Prevention of Mother to Child Transmission of HIV Activities into Maternal and Child Health Services in Cameroon under PEPFAR
Previous opportunity: Supporting the Malawi National AIDS Commission in the Coordination of National HIV Policy, Strategic Information and Capacity Building Activities in the Republic of Malawi under the President s Emergency Plan for AIDS Relief (PEPFAR)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH11 1134
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH11 1134) also looked into and applied for these:
| Funding Opportunity |
|---|
| Supporting the Ministry of Public Health, Directorate of Family Health to Integrate Comprehensive Prevention of Mother to Child Transmission of HIV Activities into Maternal and Child Health Services in Cameroon under PEPFAR Apply for CDC RFA GH11 1156 Funding Number: CDC RFA GH11 1156 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $775,200 |
| NIDCD Community Wide Scientific Resources Limited Competition (R24) Apply for PAR 11 103 Funding Number: PAR 11 103 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Strengthening the National Institutes of Health in the Republic of Mozambique under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH11 1158 Funding Number: CDC RFA GH11 1158 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Strengthening the Coordination Role of the Ministry Responsible for the Fight Against AIDS in Cote dIvoire under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH11 1198 Funding Number: CDC RFA GH11 1198 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Botswana Civil Society Strengthening Program Apply for 674 11 0003 Funding Number: 674 11 0003 Agency: South Africa USAID Pretoria Category: Health Funding Amount: $20,000,000 |
| Strategies to Increase Health Care Providers Use of Population Based Immunization Information Systems Apply for RFA IP 11 008 Funding Number: RFA IP 11 008 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $200,000 |
| Support to Local Indigenous Partners in the Implementation and Expansion of High Quality HIV Care, Prevention and Treatment Activities in Faith Based Affiliated Sites in the Republic of Guyana under the President s Emergency Plan for AIDS Relief (PEP Apply for CDC RFA GH11 1140 Funding Number: CDC RFA GH11 1140 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Supporting the National Tuberculosis Prevention Program to Conduct TB Prevention in Haiti under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH11 1195 Funding Number: CDC RFA GH11 1195 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $2,000,000 |
| Health Impact Assessment to Foster Healthy Community Design Apply for CDC RFA EH11 1104 Funding Number: CDC RFA EH11 1104 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $180,000 |
| Nurse Faculty Loan Program Apply for HRSA 11 045 Funding Number: HRSA 11 045 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Scholarships for Disadvantaged Students Apply for HRSA 11 074 Funding Number: HRSA 11 074 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Ruth K. Kirchstein National Research Service Award (NRSA) Institutional Research Training Grant Apply for HRSA 11 054 Funding Number: HRSA 11 054 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Health Promotion and Disease Prevention Research Centers Special Interest Project Competitive Supplements (SIPS) Apply for RFA DP 09 001 Funding Number: RFA DP 09 001 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Healthy Homes and Lead Poisoning Prevention Program Apply for CDC RFA EH11 1102 Funding Number: CDC RFA EH11 1102 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $600,000 |
| Telehealth Resource Center Grant Program Apply for HRSA 11 141 Funding Number: HRSA 11 141 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Part D Coordinated HIV Services and Access to Research for Women, Infant, Children and Youth Apply for HRSA 11 093 Funding Number: HRSA 11 093 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Clinical Interventions to Increase Organ Procurement Apply for HRSA 11 025 Funding Number: HRSA 11 025 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Donation and Transplantation Community of Practice Initiatives to Increase Organ Donation Apply for HRSA 11 140 Funding Number: HRSA 11 140 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| National Clinicians Consultation Center Apply for HRSA 11 105 Funding Number: HRSA 11 105 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Engaging The Medical Laboratory Science Council Of Nigeria (MLSCN), Nigeria s Laboratory Accrediting Agency, To Mentor All Tiers Of Nigeria s Public Laboratory System To Advance Them Towards National Accreditation Under PEPFAR Apply for CDC RFA GH11 1161 Funding Number: CDC RFA GH11 1161 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $500,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH11 1134", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.